Dayana B. Rivadeneira, Ph.D.
Affiliations: | 2012 | Genetics | Thomas Jefferson University, Philadelphia, PA, United States |
Area:
Molecular Biology, Genetics, OncologyGoogle:
"Dayana Rivadeneira"Parents
Sign in to add mentor| Errik S. Knudsen | grad student | 2012 | Thomas Jefferson | |
| (Novel roles of the RB-pathway in human cancers: Modifying disease progression and establishing new therapeutic opportunities.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| DePeaux K, Rivadeneira DB, Lontos K, et al. (2023) An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment. The Journal of Experimental Medicine. 220 |
| Rivadeneira DB, DePeaux K, Wang Y, et al. (2019) Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance. Immunity |
| Menk AV, Scharping NE, Rivadeneira DB, et al. (2018) 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. The Journal of Experimental Medicine |
| Rivadeneira DB, Delgoffe GM. (2018) Antitumor T cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Caino MC, Seo JH, Wang Y, et al. (2017) Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. The Journal of Clinical Investigation |
| Seo JH, Rivadeneira DB, Caino MC, et al. (2016) The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis. Plos Biology. 14: e1002507 |
| Rivadeneira DB, Caino MC, Seo JH, et al. (2015) Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion. Science Signaling. 8: ra80 |
| Caino MC, Ghosh JC, Chae YC, et al. (2015) PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America |
| Faversani A, Vaira V, Moro GP, et al. (2014) Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors. Breast Cancer Research : Bcr. 16: R55 |
| Witkiewicz AK, Cox DW, Rivadeneira D, et al. (2014) The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer. Oncogene. 33: 3980-91 |